Universe Pharmaceuticals (UPC) Equity Average (2021 - 2025)

Universe Pharmaceuticals has disclosed Equity Average across 5 years of filings, most recently posting $50.8 billion for Q3 2025.

• Equity Average for Q3 2025 came in at $50.8 billion, up 123.22% year-over-year; the trailing twelve-month figure through Sep 2025 was $50.8 billion (up 123.22% YoY), and the FY2025 annual result was $50.8 billion, up 38.33% from the prior year.
• Equity Average came in at $50.8 billion for Q3 2025 at Universe Pharmaceuticals, up from $22.8 billion in the prior quarter.
• In the past five years, Equity Average ranged from a high of $50.8 billion in Q3 2025 to a low of $33.9 million in Q3 2021.
• The 5-year median for Equity Average is $15.8 billion (2023), against an average of $17.1 billion.
• Across the five-year window, Equity Average soared 52103.81% in 2022 and fell 20.86% in 2024, its largest moves.
• Universe Pharmaceuticals' Equity Average stood at $33.9 million in 2021, then jumped by 52103.81% to $17.7 billion in 2022, then slipped by 20.84% to $14.0 billion in 2023, then soared by 62.51% to $22.8 billion in 2024, then surged by 123.22% to $50.8 billion in 2025.
• The last three Equity Average figures came in at $50.8 billion (Q3 2025), $22.8 billion (Q3 2024), and $14.0 billion (Q1 2024), per Business Quant data.